Annual report pursuant to Section 13 and 15(d)

NOTES PAYABLE (Details Narrative)

v2.4.0.6
NOTES PAYABLE (Details Narrative) (USD $)
 12 Months Ended 60 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2012
Financing Arrangement Directors and Officers Insurance
Sep. 30, 2012
Financing Arrangement Clinical Trial Insurance
Notes payable, amount       $ 48,300 $ 24,438
Notes payable, interest rate       11.50% 12.95%
Principal repaid       39,251 13,450
Interest Paid $ 1,817 $ 24,003 $ 71,740 $ 1,329 $ 488
Issuance date       Mar. 24, 2012 Jun. 30, 2012